Preethi

The science of gene therapy has advanced and is now able to deliver long-lasting cures for a growing range of ailments, despite the ups and downs experienced by the industry over the past thirty years. Numerous inherited and acquired illnesses of several organ systems are being studied in ongoing clinical trials. Hematologic stem cells (HSC), T lymphocytes, and other immune cells can be modified ex vivo, and genes or gene editing reagents can be delivered to the appropriate target cells by systemic or local administration.